|
⚲
|
| Keyboard |
| Bellini Roberto
✚
|
|
|---|---|
| CIK # | 0001802453 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001802453] | |
| 4 | [0001802453] | |
| SC 13G | [0001802453] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Bellini Roberto Francesco | Bellus Health Inc | [2020-02-06] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bellini Roberto | |
| Inhibikase Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 116,585 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 73,580 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2024-10-21 | Buy | 1,460,000 | $1.37 | 2,000,200 |
|
Inhibikase Therapeutics Inc IKT
Stock Option (right to buy) · derivative
|
2024-10-21 | Grant | 60,000 | $0.00 |